Syllable, a Sunnyvale, Calif.-based AI-enabled healthcare automation announced a $40 Million Series C funding round to further improve the patient experience with intelligent voice solutions for the call center and medical practice office.
The round was led by TCV, with participation from existing investors Oak HC/FT, Section32, and Verily.
The funding will be used to further develop Syllable’s main solution, the Syllable Patient Assistant, which meets patients where they are, on the phone, web, and via SMS.
Company: Syllable Corporation
Raised: $40.0M
Round: Series C
Funding Month: April 2022
Lead Investors: TCV
Additional Investors: Oak HC/FT, Section32, and Verily
Company Website: https://syllable.ai/
Software Category: AI-enabled healthcare services
About the Company: Syllable is an AI-enabled healthcare services company that transforms the way health systems provide access to care. Long call hold times, rerouted or dropped calls, and dead ends can contribute to a frustrating patient experience and make it cumbersome to access vital care quickly. Poor search functionality on the health system website and frustratingly hard to use patient portals confuse patients. Syllable helps patients navigate health care options with empathy, transparency, and intelligence from the moment they request care by dialing the phone or visiting a health system’s website. Since 2018, Syllable’s solutions have been in use by some of the largest and most respected health systems across the United States.
Source: https://insidernews.global/syllable-raises-40-million-series-c-led-by-tcv-to-improve-the-patient-experience-with-intelligent-voice-solutions-for-the-health-system-call-center-and-medical-practices/